Affiliated institutes

The following section outlines major research areas in institutes affiliated with the faculty. Note, although students may undertake their research at an affiliated institute they can only be enrolled through a department or an accredited academic unit of the faculty.

Baker Heart Research Institute

Hypertension; atherosclerosis; sympathetic nervous system; stress; heart failure; risk assessment; risk reduction; noradrenalin release; panic disorders; arrhythmias; phosphatidyl inositol turnover; Na⁺,Ca⁺transport; growth factors; vascular hypertrophy; heart transplantation; myocardial metabolism; mitochondria; atrial naturetic peptide; medullipin; endothelin; lipoprotein receptors; angiotensin 1 receptors; mineralocorticoid receptors; glucocorticoid receptors; receptor antagonists; 11__ß hydroxysteroid dehydrogenase; pro-opiomelanocortin; ACTH; __ß-endorphin; angiotensin II; serotonin; dopamine; central antihypertensive drugs; pituitary; hypothalamus; metalloendopeptidases; renal innervation; von Willebrand factor; platelet adhesion; GMP-140; PECAM-1; thrombosis; angiogenesis; inflammation; gene regulation.

Contact details

Visit www.med.monash.edu.au/medicine/alfred/research/baker.html

Macfarlane Burnet Institute for Medical Research and Public Health

Human immunodeficiency virus; hepatitis viruses; respiratory syncytial virus; rubella virus; influenza; rotavirus; malaria; immunology; cancer; breast cancer; epidemiology; public health and social research; communicable diseases; international health, education and community development projects in 25 countries in Asia, Africa and the Pacific.

Contact details

Visit www.med.monash.edu.au/medicine/alfred/research/macfarlane.html

Mental Health Research Institute

Psychoses and related disorders

Schizophrenia; bipolar mood disorder; delusions; clinic for treating auditory hallucinations (hearing voices); addiction and substance abuse; mechanisms of action and effects of antipsychotic medication; adjunctive treatments for psychoses; collaborative therapy; serotonin; dopamine; SNPs; GABA receptor; kainite receptor; apolipoporotein; E; estrogen.

Alzheimer's disease and neurodegeneration

Oxidative stress in neurological disorders; drug interventions against toxic effect of A-beta accumulation; amyloid precursor protein; metals in the brain; delusions in Alzheimer’s disease; ocular motor testing for early signs of disease onset; Parkinson’s disease.

Platforms

Neurochemistry; neurophysiology; psychopharmacology; genetics and proteomics; cognitive neuropsychiatry; cell biology; neuropathology; animal models for psychosis and neurodegeneration; phenotyping; neural tissues repository; clinical trials; cognitive testing and therapy.

Contact details

Visit www.mhri.edu.au

Prince Henry's Institute of Medical Research

Neuroendocrinology; molecular endocrinology; reproductive endocrinology; testicular physiology; ovarian physiology; tissue remodelling; menstruation; implantation; cardiovascular disease; endocrine cancers, particularly breast and ovarian cancers; infertility; menstrual disorders; reproductive medicine; menopause; and ageing.

Contact details

Dr Evan Simpson: telephone: + 61 3 9594 4397; email: evan.simpson@princehenrys.org or visit www.princehenrys.org

Previous page | Next page | Section contents | Title and contents